$ 69,315 Common stock issued 1,343 6,829 1,002 Common stock repurchased (4,599) (4,195) (3,033) Stock-based compensation expense 5,289 4,652 3,940 Other, net (1) 11 (1) Balance, end of period 80,552 78,520 71,223 Retained earnings Balance, beginning of period 24,150 13,682 17,769 Net income 44,281 39,240 16,571 Common stock cash dividends (15,483) (14,103) (12,917) Common stock repurchased (18,382) (15,346) (7,699) Cumulative effect of accounting changes 0 677 (42) Balance, end of period 34,566 24,150 13,682 Accumulated other comprehensive income (loss) Balance, beginning of period (340) (2,187) 627 Other comprehensive income (loss) 3,526 1,914 (2,856) Cumulative effect of accounting changes 0 (67)